Page last updated: 2024-08-25

alantolactone and bortezomib

alantolactone has been researched along with bortezomib in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bian, Y; Fu, C; Li, Z; Niu, M; Pan, B; Qiao, J; Sun, Y; Wu, Q; Xia, D; Xu, K; Yao, Y; Zhao, K; Zhu, F	1

Other Studies

1 other study(ies) available for alantolactone and bortezomib

Article	Year
Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance. Apoptosis : an international journal on programmed cell death, 2015, Volume: 20, Issue:8 Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Caspases; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; Humans; Lactones; MAP Kinase Signaling System; Multiple Myeloma; Phosphorylation; Sesquiterpenes, Eudesmane; Tumor Microenvironment	2015

Article

Year

Alantolactone induces G1 phase arrest and apoptosis of multiple myeloma cells and overcomes bortezomib resistance.

Apoptosis : an international journal on programmed cell death, 2015, Volume: 20, Issue:8

Topics: Antineoplastic Agents; Apoptosis; Bortezomib; Caspases; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; G1 Phase Cell Cycle Checkpoints; Humans; Lactones; MAP Kinase Signaling System; Multiple Myeloma; Phosphorylation; Sesquiterpenes, Eudesmane; Tumor Microenvironment

2015